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Objectives: To evaluate midterm results of mechanical valves in pulmonary
position in patients with pulmonary regurgitation and right ventricular
dysfunction as an alternative to bioprostheses. Patients: Mechanical valves
(six tilting disc valves and two bileaflet valves) were implanted in eight
patients previously operated on for tetralogy of Fallot (n 5 7) and truncus
arteriosus (n 5 1), with severe right ventricular dysfunction caused by
massive pulmonary regurgitation. Results: All patients survived prosthesis
implantation and are currently well. At follow-up (3 months to 9 years),
they do not show signs of valve failure, and right ventricular function has
dramatically improved in all but one, who still shows moderate ventricular
hypokinesia. Conclusion: After operative correction of congenital heart
defects in selected patients who show severe dysfunction of the right
ventricle caused by pulmonary regurgitation/stenosis, mechanical valves
may represent an alternative to bioprosthetic valves. The selection of the
valve type is still a matter of debate. However, according to literature data,
complications seem to have occurred only in patients with bileaflet mechan-
ical valves in the pulmonary position, whereas no thromboembolic episodes
or valve failure is reported in subjects with tilting disc valves in the right
ventricular outflow. Tilting disc valves might perform better in the right
ventricular outflow than bileaflet valves. (J Thorac Cardiovasc Surg 1998;
115:1074-9)
Continuing improvement of survival of young in-fants and children with complex congenital heart
malformations has raised concerns about the quality
of their future life and the need for further opera-
tions. In particular, the reliability and duration of
biologic valves is a matter of debate.1-5
Although mechanical valves are routinely im-
planted in “left-sided” positions and experience is
growing with these techniques, children less com-
monly undergo mechanical valve replacement on
the “right side” of the heart. In severely dilated and
hypokinetic right ventricles with pulmonary valve
dysfunction, a competent prosthetic valve with an
expected long life span is preferable. This cannot be
achieved with the commonly used biologic prosthe-
ses (porcine or homograft), which may undergo
progressive deterioration.3-6
However, reported results with prosthetic me-
chanical valves in the pulmonary position are incon-
sistent, and most authors recommend routine re-
placement of “biologic prostheses.”1, 2
We report our experience, with midterm fol-
low-up of mechanical valves in the pulmonary posi-
tion and a review of the available literature on this
controversial issue.
Patients and methods
In two unrelated pediatric cardiac surgery departments
between January 1988 and July 1997, eight patients un-
derwent implantation of a mechanical valve in the pulmo-
nary position for severe pulmonary regurgitation and right
ventricular dysfunction. Five of eight had been previously
operated on for complete correction of the malformation
in other institutions and were referred to our centers by
their own pediatric cardiologists.
Their clinical characteristics are summarized in Table I.
Seven of them had tetralogy of Fallot (TOF), in two cases
with absent pulmonary valve; one had truncus arteriosus
type 1. Their mean age at operation was 10.1 years (range
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6 to 17 years). They previously had a mean of 1.6
operations (range 1 to 4).
The decision to place a prosthetic valve was based on
several reasons: (1) In almost all, the right ventricle was
severely dilated and hypokinetic; (2) in five patients
with stenosed valved conduits, the right ventricle had to
manage high pressures (mean 170 mm Hg; range 60 to
220 mm Hg); (3) it was necessary to definitely relieve
the right ventricle from such a volume/pressure over-
load.
In all, a mechanical valve was implanted in the
pulmonary position. This option was chosen because
they were old enough to anticipate a long time before
the need for reoperation as a result of patient-valve
mismatch with somatic growth and to minimize the risks
of reoperations caused by valve degeneration as occurs
with bioprostheses. In six patients a tilting disc valve
(Sorin Biomedica spa, Saluggia, Italy, in five children
and Bjo¨rk-Shiley [Shiley, Inc., Irvine, Calif.] in one
child) was used. In five of these patients the valve was
sutured within a Dacron conduit after institution of
moderately hypothermic cardiopulmonary bypass to
connect the right ventricle with the main pulmonary
artery. In two patients a bileaflet valve was placed in the
pulmonary position.
Results
All patients survived and were discharged home
in a good condition after an uneventful early post-
operative period with anticoagulants (warfarin so-
dium [Coumadin]). They are currently receiving
anticoagulants to maintain an international normal-
ized ratio of 2.0.
The mean duration of follow-up is 6.4 years
(range 3 months to 9 years). All patients are clini-
cally well and lead normal lives. Only a 10-year-old
girl with moderately dilated and hypokinetic right
ventricle has a mild reduction in exercise tolerance.
All are in sinus rhythm and periodic Holter studies
did not show any significant arrhythmia. Cross-
sectional echocardiography and Doppler ultrasono-
graphic cardiac evaluations show complete recovery
of right ventricular function in six patients. In the
Table I. Clinical features of the seven patients who underwent placement of a mechanical valve in pulmonary
position
Patient
(year of birth) Diagnosis Previous operations
Year of
last
operation
Valve
size Type of valve Notes
Pressure
gradient at
valvular level
(mm Hg)
1. (1988) Fallot’s tetralogy 1988—valvotomy 1994 21 St. Jude Medical Well 23
1990—correction
2. (1986) Fallot’s tetralogy 1989—correction 1992 23 Sorin Mild reduction
of exercise
tolerance.
Dilated right
ventricle
25
3. (1969) Fallot’s tetralogy
with pulmonary
agenesis
1980—correction 1989 25 Sorin (1Hancock
conduit)
Well 20
4. (1978) Fallot’s tetralogy 1979—BT shunt 1988 21 Sorin (1Hancock
conduit)
Well 20
1979—central shunt
1980—correction
(1Hancock conduit)
5. (1977) Fallot’s tetralogy 1981—correction 1988 25 Duromedics Well NA
6. (1975) Fallot’s tetralogy 1978—correction
(1Hancock conduit)
1988 23 Sorin (1 Dacron
conduit)
Well 38
7. (1982) Truncus type I 1982—correction
(valved conduit)
1989 21 Bjo¨rk-Shiley
(1 Dacron
conduit)
Well NA
8. (1985) Fallot’s tetralogy 1985—BT shunt 1997 23 Sorin Well 30
1988—correction
(1Hancock conduit)
1992—patch plasty of
the RVOT
RVOT, Right ventricular outflow; BT, Blalock-Taussig; NA, not available.
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last patient to have an operation the follow-up
duration is too short to allow recovery of right
ventricular function, although a marked improve-
ment has been observed after the operation. In one
patient the ventricular wall is still moderately hyper-
trophied, and in another patient the right ventricle is
moderately dilated and hypokinetic. In all patients
only mild pressure gradients have been detected at
the valvular level (range 20 to 38 mm Hg; Table I).
Serial echocardiography did not show any evidence
of valve failure, paravalvular leak, or both. No tissue
growth (pannus) within the valve anulus has been
detected during the follow-up period.
No patient showed hemolytic anemia or throm-
botic phenomena, and none reported bleeding com-
plications caused by anticoagulant therapy.
Discussion
Valve replacement in children represents a spe-
cial problem and deserves particular considerations
because of the characteristics of these patients. In
children, prostheses should have a long life and an
orifice large enough to avoid “outgrowing” of the
child and patient-valve size mismatch. Also, antico-
agulation has been claimed as a risk factor in these
active subjects.
Although wide experience has been gathered
about “left-sided” prostheses and current guidelines
support the use of mechanical valves in the aortic
position, because of their extended functional life
free of complications, the issue of which type of
valve would perform better in the pulmonary posi-
tion is still controversial and there is a need to
establish precise criteria for the selection of patients
and valve type. In general, most authors recommend
porcine xenografts and homografts for the recon-
struction of a competent pulmonary valve.1, 2 This
attitude has been supported by the publication of
several papers reporting thrombotic complications
in patients with mechanical valves in the pulmonary
position, with a rate of complications ranging from
25% to 56%.1, 2, 7-10
Patients with severely dysfunctional right ventri-
cles are relatively uncommon because of the good
operative results attained in the past decades. How-
ever, a small proportion of these patients will have
disability develop from pulmonary regurgitation af-
ter correction of TOF. Because of the increased
postoperative and long-term survival of these pa-
tients, one may expect that the problem of a young
and active adult with a TOF corrected early in life,
who has become symptomatic or shows laboratory
signs of right ventricular dysfunction, will have in-
creasing frequency.
These patients are usually treated with pulmonary
homografts or porcine xenografts to avoid anticoag-
ulation. Bioprostheses in the pulmonary position
seem to have a good outcome, with a prolonged
survival compared with those in the aortic position.
In the series reported by Bando and colleagues,3
94% of homografts were still functioning well after 5
years. However, 24% of these valves were already
moderately or severely calcified 5 years after oper-
ation, and 10% of these children had to be reoper-
ated for homograft failure. Other authors have
reported unsatisfactory results with bioprosthetic
valves: Bull and colleagues4 had to perform second
operations for conduit obstruction or conduit valve
malfunctioning in 23 of 173 (13.3%) children and
calculated that only 15% to 27% of patients will be
free of severe complications (death or obstruction of
the conduit) 10 years after the operation. These
results led them to suggest that homografts and
heterografts in various types of conduits may not
represent a permanent solution for many children
with complex congenital heart defects. Similar re-
sults have been reported by Cleveland and col-
leagues,5 who observed a rate of conduit failure of
15% after 3 years, with an actuarial freedom from
reoperation of 55% at 5 years. They had to reoper-
ate on 50% of the patients within 8 years because of
failure of the biologic valve.
However, with the progressively increasing sur-
vival of these patients, one should try to avoid
reoperations, reducing the risks of operation and
attaining cost-containment. Indeed, reoperations
carry an increased burden of risk. Vogt and col-
leagues11 estimated that 80% of patients with right
ventricular outflow reconstruction will be free of
reoperation 18 years after initial correction of TOF.
The likelihood of reoperation increases if a conduit
had been previously used. These authors observed a
mortality rate of 9.3% at the first reoperation and
16% at the second reoperations. However, these
rates seemed to decrease with time. Patients with
the higher risk of reoperation for right ventricular
outflow tract reconstruction are probably those who
underwent “heavy” reconstructive surgery at the
initial operation and in whom conduits or transan-
nular patches were used.
These considerations have prompted us to evalu-
ate the results of mechanical valves in the pulmo-
nary position in our patients and to review the
available literature.
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All our eight patients who received a mechanical
valve in the pulmonary position are doing well and
are free of complications related to valve failure or
thromboembolic phenomena, although they are re-
ceiving anticoagulants. The duration of follow-up is
sufficiently long to reassure us about the good
results of the operation. This is also supported by
the improvement showed by all the children and by
the echocardiographic parameters. It should be
noted that six children received a tilting disc valve,
whereas a bileaflet valve was used in only two.
In the medical literature the placement of me-
chanical valves in the pulmonary position is re-
ported in less than 90 patients, with apparently
inconsistent results (Table II). Several authors
have reported moderate to severe complications
in patients with mechanical valves in the right side
of the heart.1, 2, 6-9, 12-16 Common complications
include thromboembolic phenomena, bleeding,
and valve failure. In a comparison of St. Jude
Medical (St. Jude Medical, Inc., St. Paul, Minn.)
valves and bioprostheses in the pulmonary or
tricuspid position, Kawachi and colleagues14
showed that bioprostheses have a good midterm
outcome with a low rate of valve dysfunction,
whereas St. Jude Medical valves are at high risk
for complications. These mainly anecdotal reports
led to recommend bioprosthetic valves in the
“right heart.” However, when these patients are
disaggregated by valve type, it appears that com-
plications occurred only in children with bileaflet
valves. As shown in Table II, no complications are
reported in the patients with tilting disc valves in
the pulmonary position, whereas thrombotic phe-
nomena or valve failure occurred in 35% of
children with St. Jude Medical valves. This prob-
ably depends on the different valve behavior,
which may be explained by the structural features
of the bileaflet valve; the “force threshold” they
need for adequate functioning is probably higher
than for monodisc valves, and this appears to be a
critical issue in the low-pressure system in the
“right heart.”8 This low pressure probably allows
the deposition of fibrin and the formation of
microclots, predisposing to the growth of fibrous
tissue within the valve anulus and in the hinges,
impairing the movement of the leaflets.1, 7 It may
be hypothesized that the better performance of
tilting disc valves is due to the absence of struc-
tural links between the disc and the valve ring,
where blood flow is slower and clotting with
subsequent growth of pannus are favored. One
may also hypothesize that the structural features
of monodisc valves, with the central position of
the leaflet pivot, where the blood flow is (presum-
ably) less disturbed and turbulent and its velocity
is higher, may reduce the risks of fibrin deposi-
tion, clotting formation, growth of fibrous tissue,
and, therefore, of valve failure. Thus available
clinical data suggest that tilting disc valves in the
pulmonary position may perform better than
bileaflet valves, especially because using valved
Table II. Mechanical valves in pulmonary position
First author Reference Year
Nonfailing
monodisc
valves
Failing
monodisc
valves
Nonfailing
bileaflet
valves
Failing
bileaflet
valves
Cartmill 12 1974 9 (7 survived) 0 0 0
Misbach 15 1983 2 0 0 0
Pass 9 1984 0 0 3 1
Goor 17 1984 7 0 0 0
Ilbawi 1 1986 0 0 10 6
Miyamura 7 1987 0 0 3 2
Ilbawi 2 1987 0 0 6* (No. in
tricuspid?)
8/14* (No. in
tricuspid?)
Kawachi 14 1991 0 0 7 1
Kiyota 8 1992 0 0 8 3
Fiane 6 1996 1 0 0 0
Burger 10 1997 0 0 0 1
Present study 6 0 2 0
Total 25 0 39 22
Data are disaggregated by valve type and the occurrence of complications (valve failure, thrombosis, need of reoperation).
*The data reported in this paper do not allow precise disaggregation by valve position (tricuspid or pulmonary).
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conduits may further increase their durability and
reliability. Unfortunately, we lack experimental
data on the behavior of tilting disc valves in a
low-pressure circuit.12, 17
Although these figures are small and long-term
follow-up is lacking, we would agree with Dr.
Ilbawi’s recommendation about a “word of cau-
tion regarding right side placement”1 of bileaflet
mechanical valves; we would also suggest a thor-
ough reevaluation of tilting disc valves in the
pulmonary position. Should their reliability be
confirmed, the use of mechanical valves in care-
fully selected patients might result in a satisfac-
tory outcome, comparable at least to bioprosthe-
ses but possibly reducing the risk of reoperation
because of calcification and stenosis. Anticoagu-
lation carries some risk of thromboembolic
events, which cannot be overlooked. Bradley and
colleagues18 have recently reviewed their series
and conducted an analysis of related papers: the
risk of thromboembolic events in children with
mechanical valves (mitral or aortic position) is
about 4%. Obviously, these figures should enter
the risks/benefits balance when considering this
particular type of surgery. An important issue that
should not be overlooked is future pregnancy in
patients with prosthetic valves. Bioprostheses
show an enhanced deterioration during pregnancy
because of aggressive calcification and early re-
placement may add uncertain risks; on the other
hand, in patients with mechanical valves, warfarin
sodium and heparin carry some risks for both
mother and fetus, but these drugs should not be
discontinued during pregnancy. Surveillance of
pregnant patients with mechanical valves, as well
as of the fetus, should be very close.19, 20
In conclusion in selected patients with severe
dysfunction of the right ventricle because of pul-
monary regurgitation, the use of a mechanical
valve in the pulmonary position may be taken into
consideration as an alternative option to biopros-
theses to reduce the risk of reoperations. In
addition, redo operations consume resources that,
conversely, could progressively decrease with
time. Our series is clearly small, and this is not a
controlled study; therefore reliable statistics can-
not be drawn. Larger prospective studies should
be conducted before one may routinely consider
mechanical valves as a safe alternative to biopros-
theses in the pulmonary position. In the pulmo-
nary position, tilting disc valves seem to function
better than bileaflet valves.
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